These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20488500)

  • 1. Pharmacokinetics of nicorandil in dogs with mild mitral regurgitation.
    Fukunaga K; Fujii Y; Chiba N; Ueshima A; Wakao Y; Mishima K; Fujiwara M; Orito K
    Res Vet Sci; 2011 Feb; 90(1):95-8. PubMed ID: 20488500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma digoxin concentration in dogs with mitral regurgitation.
    Nagashima Y; Hirao H; Furukawa S; Hoshi K; Akahane M; Tanaka R; Yamane Y
    J Vet Med Sci; 2001 Nov; 63(11):1199-202. PubMed ID: 11767053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the tissue reninangiotensin-aldosterone system in dogs with chronic mild regurgitation through the mitral valve.
    Fujii Y; Orito K; Muto M; Wakao Y
    Am J Vet Res; 2007 Oct; 68(10):1045-50. PubMed ID: 17916008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
    Thomason JD; Rockwell JE; Fallaw TK; Calvert CA
    J Vet Cardiol; 2007 Nov; 9(2):103-8. PubMed ID: 17983885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body size, but neither age nor asymptomatic mitral regurgitation, influences plasma concentrations of dimethylarginines in dogs.
    Pedersen LG; Tarnow I; Olsen LH; Teerlink T; Pedersen HD
    Res Vet Sci; 2006 Jun; 80(3):336-42. PubMed ID: 16182327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy.
    Ware WA; Lund DD; Subieta AR; Schmid PG
    J Am Vet Med Assoc; 1990 Dec; 197(11):1475-81. PubMed ID: 2272879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nicorandil, a potassium channel opener, on idiopathic ventricular tachycardia.
    Kobayashi Y; Miyata A; Tanno K; Kikushima S; Baba T; Katagiri T
    J Am Coll Cardiol; 1998 Nov; 32(5):1377-83. PubMed ID: 9809951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in platelet function in Dachshunds with early stages of myxomatous mitral valve disease.
    Moesgaard SG; Sørensen TM; Sterup A; Tarnow I; Kristensen AT; Jensen AL; Olsen LH
    Res Vet Sci; 2009 Apr; 86(2):320-4. PubMed ID: 18789461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs.
    Häggström J; Hansson K; Kvart C; Karlberg BE; Vuolteenaho O; Olsson K
    Am J Vet Res; 1997 Jan; 58(1):77-82. PubMed ID: 8989501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
    Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydralazine Therapy for severe mitral regurgitation in a dog.
    Kittleson MD; Hamlin RL
    J Am Vet Med Assoc; 1981 Nov; 179(9):903-5. PubMed ID: 7341606
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantification of mitral regurgitation using proximal isovelocity surface area method in dogs.
    Choi H; Lee K; Lee H; Lee Y; Chang D; Eom K; Youn H; Choi M; Yoon J
    J Vet Sci; 2004 Jun; 5(2):163-71. PubMed ID: 15192345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine changes in Dachshunds with mitral valve prolapse examined under different study conditions.
    Pedersen HD; Olsen LH; Mow T; Christensen NJ
    Res Vet Sci; 1999 Feb; 66(1):11-7. PubMed ID: 10088706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic management of myxomatous mitral valve disease in dogs.
    Atkins CE; Häggström J
    J Vet Cardiol; 2012 Mar; 14(1):165-84. PubMed ID: 22386553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral hydralazine therapy for chronic mitral regurgitation in the dog.
    Kittleson MD; Eyster GE; Olivier NB; Anderson LK
    J Am Vet Med Assoc; 1983 Jun; 182(11):1205-9. PubMed ID: 6863134
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardioprotective effects of K(ATP) channel opener nicorandil during ischemia/ reperfusion in dogs].
    Feng L; Qiu J; Ma J; Huang XB; Cha DG; Bin JP
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Mar; 17(3):157-60. PubMed ID: 15760526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pimobendan for mitral valve regurgitation in dogs.
    Kanno N; Kuse H; Kawasaki M; Hara A; Kano R; Sasaki Y
    J Vet Med Sci; 2007 Apr; 69(4):373-7. PubMed ID: 17485924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on treatment and prognostic indicators in canine myxomatous mitral valve disease.
    Häggström J; Höglund K; Borgarelli M
    J Small Anim Pract; 2009 Sep; 50 Suppl 1():25-33. PubMed ID: 19765217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between activation of the sympathetic nervous system estimated by plasma concentrations of norepinephrine and Doppler echocardiographic variables in dogs with acquired heart disease.
    Marcondes Santos M; Strunz CM; Larsson MH
    Am J Vet Res; 2006 Jul; 67(7):1163-8. PubMed ID: 16817737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of furosemide on left atrial pressure in dogs with mitral valve regurgitation.
    Suzuki S; Ishikawa T; Hamabe L; Aytemiz D; Huai-Che H; Fukushima R; Machida N; Tanaka R
    J Vet Intern Med; 2011; 25(2):244-50. PubMed ID: 21314718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.